Biopsy-to-treatment delay in prostate cancer: Postpandemic impact in a swiss national, multicenter, prospective registry.
- DOI
- 10.1016/j.urolonc.2026.06.016
- Published
- 2026 Sep
- Container
- Urologic oncology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.urolonc.2026.06.016,
title = {Biopsy-to-treatment delay in prostate cancer: Postpandemic impact in a swiss national, multicenter, prospective registry.},
author = {Winistoerfer T and Scuderi S and Gandaglia G and Arnold N and Röthlisberger R and Abt D and Nguyen DP and Engeler D and Strebel R and Schneidewind L and Thalmann G and Roth B and Giudici N and Swiss Urology Registry Collaborative Group},
year = {2026},
journal = {Urologic oncology},
doi = {10.1016/j.urolonc.2026.06.016},
url = {https://doi.org/10.1016/j.urolonc.2026.06.016}
}RIS
TY - JOUR TI - Biopsy-to-treatment delay in prostate cancer: Postpandemic impact in a swiss national, multicenter, prospective registry. AU - Winistoerfer T AU - Scuderi S AU - Gandaglia G AU - Arnold N AU - Röthlisberger R AU - Abt D AU - Nguyen DP AU - Engeler D AU - Strebel R AU - Schneidewind L AU - Thalmann G AU - Roth B AU - Giudici N AU - Swiss Urology Registry Collaborative Group PY - 2026 JO - Urologic oncology DO - 10.1016/j.urolonc.2026.06.016 UR - https://doi.org/10.1016/j.urolonc.2026.06.016 ER -
APA
T, W., S, S., G, G., N, A., R, R., D, A., DP, N., D, E., R, S., L, S., G, T., B, R., N, G., & Group, S. U. R. C. (2026). Biopsy-to-treatment delay in prostate cancer: Postpandemic impact in a swiss national, multicenter, prospective registry.. Urologic oncology. https://doi.org/10.1016/j.urolonc.2026.06.016
Source records
- pubmed · retrieved 2026-09-27T10:12:56.753Z
- europe-pmc · retrieved 2026-09-27T10:12:56.751Z